Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1985 Mar;19(3):301-5.
doi: 10.1111/j.1365-2125.1985.tb02647.x.

The effect of secoverine hydrochloride on stimulated sigmoid motility: a double-blind, placebo controlled cross-over study in irritable bowel syndrome

M Ehsanullah, D A Lee, T Williams, P Pollard, B Gazzard
Clinical Trial

The effect of secoverine hydrochloride on stimulated sigmoid motility: a double-blind, placebo controlled cross-over study in irritable bowel syndrome

M Ehsanullah et al. Br J Clin Pharmacol. 1985 Mar.

Abstract

The effect of oral secoverine hydrochloride on neostigmine-stimulated sigmoid motility in 12 patients with irritable bowel syndrome was studied in a double-blind placebo-controlled cross-over study. Both spontaneous and stimulated motor activity were significantly reduced by the compound in comparison with placebo. The most sensitive indices were the frequency of wave activity, maximum amplitude and motility index. Two patients reported mild dizziness after secoverine.

PubMed Disclaimer

References

    1. Gut. 1969 Jan;10(1):19-31 - PubMed
    1. Med J Aust. 1972 May 27;1(22):1126-31 - PubMed
    1. Gut. 1974 Aug;15(8):599-607 - PubMed
    1. N Engl J Med. 1978 Apr 20;298(16):878-83 - PubMed
    1. Br Med J. 1978 Sep 2;2(6138):653-4 - PubMed

Publication types